Literature DB >> 23470835

Regulation of Wnt/β-catenin signaling within and from osteocytes.

Travis A Burgers1, Bart O Williams.   

Abstract

Bone has long been known to be responsive to mechanical loading. For at least 25 years it has been known that osteocytes sense mechanical load, and because of their response to mechanical loading, osteocytes are believed to be the mechanosensory cell. The Wnt/β-catenin signaling pathway has been shown to be crucial in bone development. Mutations in LRP5 and SOST, which cause high bone mass, have increased interest in the Wnt pathway as a potential target for osteoporosis therapy and have helped link Wnt/β-catenin signaling to bone's response to mechanical loading. Because of its specificity to osteocytes, the Wnt inhibitor sclerostin is a target for anabolic bone therapies. The response of bone to mechanical loading is critically regulated by osteocytes secreting sclerostin, which binds to Lrp5.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23470835      PMCID: PMC3652284          DOI: 10.1016/j.bone.2013.02.022

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  101 in total

1.  Femoral neck structure in adult female athletes subjected to different loading modalities.

Authors:  Riku Nikander; Harri Sievänen; Ari Heinonen; Pekka Kannus
Journal:  J Bone Miner Res       Date:  2004-11-29       Impact factor: 6.741

2.  Three-dimensional reconstruction of chick calvarial osteocytes and their cell processes using confocal microscopy.

Authors:  Yasuyo Sugawara; Hiroshi Kamioka; Tadashi Honjo; Ken-ichi Tezuka; Teruko Takano-Yamamoto
Journal:  Bone       Date:  2005-04-07       Impact factor: 4.398

3.  LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development.

Authors:  Y Gong; R B Slee; N Fukai; G Rawadi; S Roman-Roman; A M Reginato; H Wang; T Cundy; F H Glorieux; D Lev; M Zacharin; K Oexle; J Marcelino; W Suwairi; S Heeger; G Sabatakos; S Apte; W N Adkins; J Allgrove; M Arslan-Kirchner; J A Batch; P Beighton; G C Black; R G Boles; L M Boon; C Borrone; H G Brunner; G F Carle; B Dallapiccola; A De Paepe; B Floege; M L Halfhide; B Hall; R C Hennekam; T Hirose; A Jans; H Jüppner; C A Kim; K Keppler-Noreuil; A Kohlschuetter; D LaCombe; M Lambert; E Lemyre; T Letteboer; L Peltonen; R S Ramesar; M Romanengo; H Somer; E Steichen-Gersdorf; B Steinmann; B Sullivan; A Superti-Furga; W Swoboda; M J van den Boogaard; W Van Hul; M Vikkula; M Votruba; B Zabel; T Garcia; R Baron; B R Olsen; M L Warman
Journal:  Cell       Date:  2001-11-16       Impact factor: 41.582

4.  A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait.

Authors:  Randall D Little; John P Carulli; Richard G Del Mastro; Josée Dupuis; Mark Osborne; Colleen Folz; Susan P Manning; Pamela M Swain; Shan-Chuan Zhao; Brenda Eustace; Michelle M Lappe; Lia Spitzer; Susan Zweier; Karen Braunschweiger; Youssef Benchekroun; Xintong Hu; Ronald Adair; Linda Chee; Michael G FitzGerald; Craig Tulig; Anthony Caruso; Nia Tzellas; Alicia Bawa; Barbara Franklin; Shannon McGuire; Xavier Nogues; Gordon Gong; Kristina M Allen; Anthony Anisowicz; Arturo J Morales; Peter T Lomedico; Susan M Recker; Paul Van Eerdewegh; Robert R Recker; Mark L Johnson
Journal:  Am J Hum Genet       Date:  2001-12-03       Impact factor: 11.025

5.  Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling.

Authors:  Minrong Ai; Sheri L Holmen; Wim Van Hul; Bart O Williams; Matthew L Warman
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

Review 6.  SOST/sclerostin, an osteocyte-derived negative regulator of bone formation.

Authors:  Rutger L van Bezooijen; Peter ten Dijke; Socrates E Papapoulos; Clemens W G M Löwik
Journal:  Cytokine Growth Factor Rev       Date:  2005-06       Impact factor: 7.638

7.  Essential role of beta-catenin in postnatal bone acquisition.

Authors:  Sheri L Holmen; Cassandra R Zylstra; Aditi Mukherjee; Robert E Sigler; Marie-Claude Faugere; Mary L Bouxsein; Lianfu Deng; Thomas L Clemens; Bart O Williams
Journal:  J Biol Chem       Date:  2005-03-31       Impact factor: 5.157

8.  Interaction of frizzled related protein (FRP) with Wnt ligands and the frizzled receptor suggests alternative mechanisms for FRP inhibition of Wnt signaling.

Authors:  A Bafico; A Gazit; T Pramila; P W Finch; A Yaniv; S A Aaronson
Journal:  J Biol Chem       Date:  1999-06-04       Impact factor: 5.157

9.  Decreased BMD and limb deformities in mice carrying mutations in both Lrp5 and Lrp6.

Authors:  Sheri L Holmen; Troy A Giambernardi; Cassandra R Zylstra; Bree D Buckner-Berghuis; James H Resau; J Fred Hess; Vaida Glatt; Mary L Bouxsein; Minrong Ai; Matthew L Warman; Bart O Williams
Journal:  J Bone Miner Res       Date:  2004-09-13       Impact factor: 6.741

10.  Cortical and trabecular bone at the forearm show different adaptation patterns in response to tennis playing.

Authors:  Gaële Ducher; Stéphanie Prouteau; Daniel Courteix; Claude-Laurent Benhamou
Journal:  J Clin Densitom       Date:  2004       Impact factor: 2.963

View more
  52 in total

1.  Effect of Small-molecule GSK3 Antagonist on Differentiation of Rat Dental Pulp Cells into Odontoblasts.

Authors:  Yoshiko Masuda; Hiroshi Sakagami; Satoshi Yokose; Nobuyuki Udagawa
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  Osteoblasts protect AML cells from SDF-1-induced apoptosis.

Authors:  Kimberly N Kremer; Amel Dudakovic; Meghan E McGee-Lawrence; Rachael L Philips; Allan D Hess; B Douglas Smith; Andre J van Wijnen; Judith E Karp; Scott H Kaufmann; Jennifer J Westendorf; Karen E Hedin
Journal:  J Cell Biochem       Date:  2014-06       Impact factor: 4.429

Review 3.  The genetics of bone mass and susceptibility to bone diseases.

Authors:  David Karasik; Fernando Rivadeneira; Mark L Johnson
Journal:  Nat Rev Rheumatol       Date:  2016-04-07       Impact factor: 20.543

4.  Antagonism of canonical Wnt/β-catenin signaling: taking RAS blockade to the next level?

Authors:  Jürgen Floege
Journal:  J Am Soc Nephrol       Date:  2014-07-10       Impact factor: 10.121

5.  Communication of cAMP by connexin43 gap junctions regulates osteoblast signaling and gene expression.

Authors:  Aditi Gupta; Hidayah Anderson; Atum M Buo; Megan C Moorer; Margaret Ren; Joseph P Stains
Journal:  Cell Signal       Date:  2016-05-06       Impact factor: 4.315

Review 6.  Molecular mechanosensors in osteocytes.

Authors:  Lei Qin; Wen Liu; Huiling Cao; Guozhi Xiao
Journal:  Bone Res       Date:  2020-06-08       Impact factor: 13.567

7.  Osteocyte Death and Bone Overgrowth in Mice Lacking Fibroblast Growth Factor Receptors 1 and 2 in Mature Osteoblasts and Osteocytes.

Authors:  Jennifer McKenzie; Craig Smith; Kannan Karuppaiah; Joshua Langberg; Matthew J Silva; David M Ornitz
Journal:  J Bone Miner Res       Date:  2019-06-17       Impact factor: 6.741

Review 8.  Wnt signaling in cardiovascular disease: opportunities and challenges.

Authors:  Austin Gay; Dwight A Towler
Journal:  Curr Opin Lipidol       Date:  2017-10       Impact factor: 4.776

Review 9.  Exploiting the WNT Signaling Pathway for Clinical Purposes.

Authors:  Mark L Johnson; Robert R Recker
Journal:  Curr Osteoporos Rep       Date:  2017-06       Impact factor: 5.096

10.  Fracture healing in mice lacking Pten in osteoblasts: a micro-computed tomography image-based analysis of the mechanical properties of the femur.

Authors:  Caitlyn J Collins; Juan F Vivanco; Scott A Sokn; Bart O Williams; Travis A Burgers; Heidi-Lynn Ploeg
Journal:  J Biomech       Date:  2014-11-28       Impact factor: 2.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.